PolyPeptide Group AG (SWX:PPGN)
Switzerland · Delayed Price · Currency is CHF 40.35
-0.05 (-0.12%)
Nov 12, 2026, 9:26 AM CET
PolyPeptide Group AG Market Cap
PolyPeptide Group AG has a market cap or net worth of 1.33 billion as of November 11, 2026. It is the 7,629th most valuable company in the world and the 107th biggest in Switzerland. Its market cap has increased by 67.90% in one year.
Market Cap
1.33B
Enterprise Value
1.42B
Revenue
423.58M
Global Rank
Country Rank
#107 Switzerland
PE Ratio
98.68
ChartMarket Cap Chart
Since April 29, 2021, PolyPeptide Group AG's market cap has decreased from 2.59B to 1.33B, a decrease of -48.57%. That is a compound annual growth rate of -11.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 1.33B | 54.71% |
| Dec 30, 2025 | 861.08M | -8.08% |
| Dec 30, 2024 | 936.73M | 62.30% |
| Dec 29, 2023 | 577.18M | -30.79% |
| Dec 30, 2022 | 833.98M | -81.57% |
| Dec 30, 2021 | 4.53B | 74.70% |
| Apr 29, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 321.09B |
| Novartis AG | 253.98B |
| Lonza Group AG | 46.17B |
| Galderma Group AG | 43.97B |
| SKAN Group AG | 1.54B |
| Medartis Holding AG | 1.34B |
| Aevis Victoria | 1.21B |
| Idorsia | 1.11B |